From: Immune phenotype of patients with stage IV metastatic inflammatory breast cancer
IBC patients | Healthy donors | p values | |
---|---|---|---|
Total lymphocytes per μl | 897 ± 413 | 1976 ± 855 | 0.00018 |
CD3+ T cells per μl | 646 ± 350 | 1496 ± 762 | 0.00051 |
CD8+ T cells per μl | 222 ± 117 | 458 ± 215 | 0.015 |
CD4+ T cells per μl | 372 ± 236 | 873 ± 701 | 0.00093 |
CD4+CD8+ cells per μl | 6 ± 5 | 14 ± 104 | 0.0030 |
NK cells per μl | 117 ± 80 | 296 ± 142 | 0.00076 |
B cells per μl | 137 ± 101 | 223 ± 96 | 0.017 |
CD4/CD8 ratio | 1.7 ± 0.7 | 2.6 ± 1.6 | 0.023 |
CD4+ central memory cells per μl | 165 ± 88 | 335 ± 296 | 0.00051 |
CD4+ effector cells per μl | 1 ± 29 | 12 ± 13 | 0.0034 |
CD4+ effector memory cells per μl | 68 ± 39 | 136 ± 91 | 0.0016 |
CD4+ naïve cells per μl | 125 ± 126 | 382 ± 330 | 0.00093 |
CD8+ central memory cells per μl | 20 ± 32 | 49 ± 32 | 0.0048 |
CD8+ effector cells per μl | 43 ± 39 | 87 ± 56 | 0.37 |
CD8+ effector memory cells per μl | 46 ± 54 | 112 ± 77 | 0.035 |
CD8+ naïve cells per μl | 89 ± 68 | 168 ± 131 | 0.052 |
CD16 GMFI on CD56bright NK cells | 4896 ± 3883 | 3224 ± 1361 | 0.023 |
Granzyme B GMFI on CD56bright NK cells | 1257 ± 1064 | 578 ± 474 | 0.049 |
Perforin GMFI on CD56bright NK cells | 9412 ± 18,059 | 4564 ± 4717 | 0.049 |